Assignee
FRED HUTCHINSON CANCER CENTER
US·57 granted patents·90 pending applications·14 citations·filing 2016–2025
Top patents by PatentIndex Score
147 records- 0190US2024417790A1Compositions and methods for accurately identifying mutationsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 0290US2024401128A1Compositions and methods for accurately identifying mutationsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 0390US2024409996A1Compositions and methods for accurately identifying mutationsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 0489US2024200131A1Compositions and methods for accurately identifying mutationsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 0588US12584114B2Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseFRED HUTCHINSON CANCER CENTER·Filed 2024·Granted Mar 24, 2026·0 cites·21 claims
- 0688US11725210B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Aug 15, 2023·4 cites·22 claims
- 0786US11890303B2Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapseFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Feb 6, 2024·1 cites·19 claims
- 0886US2025235488A1Compositions and methods for providing hematopoietic functionFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 0985US11458191B2Binding proteins specific for RAS neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Oct 4, 2022·1 cites·30 claims
- 1085US2024390491A1Method and compositions for cellular immunotherapyFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1184US12012443B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jun 18, 2024·1 cites·16 claims
- 1284US11879018B2Circular tandem repeat proteinsFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jan 23, 2024·1 cites·20 claims
- 1384US11382954B2Binding proteins specific for RAS neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jul 12, 2022·1 cites·30 claims
- 1484US2023193381A1Compositions and methods for accurately identifying mutationsFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 1583US11834511B2Compositions and methods for CD20 immunotherapyFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Dec 5, 2023·1 cites·22 claims
- 1683US2022349004A1Compositions and methods for accurately identifying mutationsFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 1782US11932691B2Anti-ROR1 antibodies and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Mar 19, 2024·1 cites·33 claims
- 1881US2025235470A1Methods and Compositions for Inhibiting the Growth and/or proliferation of MYC-Driven Tumor CellsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1979US2025109180A1Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 2078US11566061B2Systems and methods to improve vaccine efficacyFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jan 31, 2023·1 cites·28 claims
- 2178US2024398758A1Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of myc-driven tumor cellsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 2278US2024352119A1Anti-ror1 antibodies and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 2378US2025114433A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 2477US11872195B2Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriersFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jan 16, 2024·1 cites·19 claims
- 2575US2024033293A1Scaffolds to treat solid tumor cells and escape variantsFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 2674US12016880B2Halogen treatment of heart attack and ischemic injuryFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jun 25, 2024·0 cites·22 claims
- 2773US12295973B2Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cellsFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 2872US11905511B2Method of measuring adaptive immunityFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Feb 20, 2024·0 cites·3 claims
- 2972US11718876B2Compositions and methods for detecting allogeneic matter in a subjectFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Aug 8, 2023·0 cites·19 claims
- 3072US2023364183A1Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 3171US12365906B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted Jul 22, 2025·0 cites·43 claims
- 3271US11993652B2Tagged chimeric effector molecules and receptors thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 28, 2024·0 cites·25 claims
- 3371US11648290B2Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 16, 2023·0 cites·20 claims
- 3471US2023139737A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 3571US2023279505A1Methods and materials for canine breed identificationFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 3671US2024041933A1Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 3769US12551549B2Methods of eliciting antibodies that bind to full-length glycosylated HIV-1 ENV using multimerized ENV coresFRED HUTCHINSON CANCER CENTER·Filed 2024·Granted Feb 17, 2026·0 cites·20 claims
- 3869US2025376789A1Cell-stored barcoded deep mutational scanning libraries and uses of the sameFRED HUTCHINSON CANCER CENTER·Filed 2025·Application pending·0 cites
- 3969US2023312674A1Systems and methods to improve vaccine efficacyFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 4068US2026042821A1Human metapneumovirus antibodies and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 4168US2025144139A1Chimeric antigen receptors binding steap1FRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 4267US12442021B2Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapiesFRED HUTCHINSON CANCER CENTER·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 4367US11718875B2Compositions and methods for detecting allogeneic matter in a subjectFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Aug 8, 2023·0 cites·8 claims
- 4467US11548923B2Peptide compositions and methods of use thereof for disrupting TEAD interactionsFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jan 10, 2023·1 cites·39 claims
- 4567US2026091114A1Chimeric antigen receptors binding nectin-4FRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 4667US2024279307A1Tcrs specific for minor histocompatibility (h) antigen ha-1 and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 4766US12589145B2Systems to produce B cells genetically modified to express selected antibodiesFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted Mar 31, 2026·0 cites·20 claims
- 4866US2024412878A1Personalized insights into tumor evolution and ai-based treatment decision support systems and methodsFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 4966US2024166758A1Combination therapies for treatment of bcma-related cancers and autoimmune disordersFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 5066US2023003733A1Biomarkers and uses thereof for selecting immunotherapy interventionFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
Showing the top 50 of 147 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when FRED HUTCHINSON CANCER CENTER files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →